Abstract
Original language | English |
---|---|
Article number | 9275 |
Journal | Scientific Reports |
Volume | 13 |
Issue number | 1 |
DOIs | |
Publication status | Published - 1 Dec 2023 |
Funding
This study was funded by the Canadian Institutes of Health Research (CIHR, KRS-134297). Mr. López Malo Vázquez de Lara was supported by the Mitacs Globalink Research Internship Program. Mr. Bhandari was supported by a studentship from the Research Institute of the McGill University Health Centre. Drs. Wu and Levis were supported by Fonds de recherche du Québec—Santé (FRQS) Postdoctoral Training Fellowships. Drs. Thombs and Benedetti were supported by a FRQS researcher salary award. Ms. Neupane was supported by G.R. Caverhill Fellowship from the Faculty of Medicine, McGill University. Ms. Rice was supported by a Vanier Canada Graduate Scholarship. Ms. Riehm and Ms. Saadat were supported by CIHR Frederick Banting and Charles Best Canada Graduate Scholarship master’s awards. The primary studies by Fiest et al. and Amoozegar et al. were supported by the Cumming School of Medicine, University of Calgary, and Alberta Health Services through the Calgary Health Trust, as well as the Hotchkiss Brain Institute. Dr. Patten was supported by a Senior Health Scholar award from Alberta Innovates Health Solutions. Dr. Jetté was supported by a Canada Research Chair in Neurological Health Services Research and an AIHS Population Health Investigator Award. Collection of data for the study by Arroll et al. was supported by a project grant from the Health Research Council of New Zealand. Data collection for the study by Ayalon et al. was supported from a grant from Lundbeck International. The primary study by Khamseh et al. was supported by a grant (M-288) from Tehran University of Medical Sciences. The primary study by Bombardier et al. was supported by the Department of Education, National Institute on Disability and Rehabilitation Research, Spinal Cord Injury Model Systems: University of Washington (Grant No. H133N060033), Baylor College of Medicine (Grant No. H133N060003), and University of Michigan (Grant No. H133N060032). Collection of data for the primary study by Kiely et al. was supported by National Health and Medical Research Council (Grant Number 1002160) and Safe Work Australia. Dr. Butterworth was supported by Australian Research Council Future Fellowship (FT130101444). Collection of data for the primary study by Zhang et al. was supported by the European Foundation for Study of Diabetes, the Chinese Diabetes Society, Lilly Foundation, Asia Diabetes Foundation and Liao Wun Yuk Diabetes Memorial Fund. Dr. Conwell received support from NIMH (R24MH071604) and the Centers for Disease Control and Prevention (R49 CE002093). Collection of data for the primary study by Delgadillo et al. was supported by grant from St. Anne’s Community Services, Leeds, United Kingdom. Collection of data for the primary study by Fann et al. was supported by Grant RO1 HD39415 from the US National Center for Medical Rehabilitation Research. The primary study by Fischer et al. was funded by the German Federal Ministry of Education and Research (01GY1150). Data for the primary study by Gelaye et al. was supported by grant from the NIH (T37 MD001449). Collection of data for the primary study by Gjerdingen et al. was supported by grants from the NIMH (R34 MH072925, K02 MH65919, P30 DK50456). The primary study by Eack et al. was funded by the NIMH (R24 MH56858). Collection of data for the primary study by Hobfoll et al. was made possible in part from grants from NIMH (RO1 MH073687) and the Ohio Board of Regents. Dr. Hall received support from a grant awarded by the Research and Development Administration Office, University of Macau (MYRG2015-00109-FSS). Collection of data provided by Drs. Härter and Reuter was supported by the Federal Ministry of Education and Research (Grants No. 01 GD 9802/4 and 01 GD 0101) and by the Federation of German Pension Insurance Institute. The primary study by Henkel et al. was funded by the German Ministry of Research and Education. The primary study by Hides et al. was funded by the Perpetual Trustees, Flora and Frank Leith Charitable Trust, Jack Brockhoff Foundation, Grosvenor Settlement, Sunshine Foundation and Danks Trust. Data for the study by Razykov et al. was collected by the Canadian Scleroderma Research Group, which was funded by the CIHR (FRN 83518), the Scleroderma Society of Canada, the Scleroderma Society of Ontario, the Scleroderma Society of Saskatchewan, Sclérodermie Québec, the Cure Scleroderma Foundation, Inova Diagnostics Inc., Euroimmun, FRQS, the Canadian Arthritis Network, and the Lady Davis Institute of Medical Research of the Jewish General Hospital, Montréal, QC. Dr. Hudson was supported by a FRQS Senior Investigator Award. Collection of data for the primary study by Hyphantis et al. (2014) was supported by grant from the National Strategic Reference Framework, European Union, and the Greek Ministry of Education, Lifelong Learning and Religious Affairs (ARISTEIA-ABREVIATE, 1259). The primary study by Inagaki et al. was supported by the Ministry of Health, Labour and Welfare, Japan. The primary study by Twist et al. was funded by the UK National Institute for Health Research under its Programme Grants for Applied Research Programme (Grant Reference Number RP-PG-0606-1142). The primary study by Lamers et al. was funded by the Netherlands Organisation for Health Research and development (Grant Number 945-03-047). The primary study by Liu et al. (2011) was funded by a grant from the National Health Research Institute, Republic of China (NHRI-EX97-9706PI). The primary study by Lotrakul et al. was supported by the Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand (Grant Number 49086). The primary studies by Osório et al. (2012) were funded by Reitoria de Pesquisa da Universidade de São Paulo (Grant Number 09.1.01689.17.7) and Banco Santander (Grant Number 10.1.01232.17.9). Dr. Osório was supported by Productivity Grants (PQ-CNPq-2-Number 301321/2016-7). Dr. Bernd Löwe received research grants from Pfizer, Germany, and from the medical faculty of the University of Heidelberg, Germany (Project 121/2000) for the study by Gräfe et al. Collection of data for the primary study by Williams et al. was supported by a NIMH grant to Dr. Marsh (RO1-MH069666). The primary study by Mohd Sidik et al. was funded under the Research University Grant Scheme from Universiti Putra Malaysia, Malaysia and the Postgraduate Research Student Support Accounts of the University of Auckland, New Zealand. The primary study by Santos et al. was funded by the National Program for Centers of Excellence (PRONEX/FAPERGS/CNPq, Brazil). The primary study by Muramatsu et al. (2007) was supported by an educational grant from Pfizer US Pharmaceutical Inc. Collection of primary data for the study by Pence et al. was provided by NIMH (R34MH084673). The primary study by Persoons et al. was partly funded by a grant from the Belgian Ministry of Public Health and Social Affairs and supported by a limited grant from Pfizer Belgium. The primary study by Picardi et al. was supported by funds for current research from the Italian Ministry of Health. The primary study by Rooney et al. was funded by the United Kingdom National Health Service Lothian Neuro-Oncology Endowment Fund. Dr. Shaaban was supported by funding from Universiti Sains Malaysia. The primary study by Sidebottom et al. was funded by a grant from the United States Department of Health and Human Services, Health Resources and Services Administration (Grant Number R40MC07840). Simning et al.’s research was supported in part by grants from the NIH (T32 GM07356), Agency for Healthcare Research and Quality (R36 HS018246), NIMH (R24 MH071604), and the National Center for Research Resources (TL1 RR024135). Dr. Stafford received PhD scholarship funding from the University of Melbourne. Collection of data for the studies by Turner et al. (2012) were funded by a bequest from Jennie Thomas through the Hunter Medical Research Institute. The study by van Steenbergen-Weijenburg et al. was funded by Innovatiefonds Zorgverzekeraars. The study by Wittkampf et al. was funded by The Netherlands Organization for Health Research and Development (ZonMw) Mental Health Program (nos. 100.003.005 and 100.002.021) and the Academic Medical Center/University of Amsterdam. Dr Vöhringer was supported by the Fund for Innovation and Competitiveness of the Chilean Ministry of Economy, Development and Tourism, through the Millennium Scientific Initiative (Grant Number IS130005). The primary study by Thombs et al. was done with data from the Heart and Soul Study. The Heart and Soul Study was funded by the Department of Veterans Epidemiology Merit Review Program, the Department of Veterans Affairs Health Services Research and Development service, the National Heart Lung and Blood Institute (R01 HL079235), the American Federation for Aging Research, the Robert Wood Johnson Foundation, and the Ischemia Research and Education Foundation.No other authors reported funding for primary studies or for their work on the present study. All authors have completed the ICJME uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years with the following exceptions: Dr. Chan J CN is a steering committee member and/or consultant of Astra Zeneca, Bayer, Lilly, MSD and Pfizer. She has received sponsorships and honorarium for giving lectures and providing consultancy and her affiliated institution has received research grants from these companies. Dr. Hegerl declares that within the last three years, he was an advisory board member for Lundbeck and Servier; a consultant for Bayer Pharma; a speaker for Pharma and Servier; and received personal fees from Janssen Janssen and a research grant from Medice, all outside the submitted work. Dr. Inagaki declares that he has received a grant from Novartis Pharma, and personal fees from Meiji, Mochida, Takeda, Novartis, Yoshitomi, Pfizer, Eisai, Otsuka, MSD, Technomics, and Sumitomo Dainippon, all outside of the submitted work. Dr. Ismail declares that she has received honorarium for speaker fees for educational lectures for Sanofi, Sunovion, Janssen and Novo Nordisk. All authors declare no other relationships or activities that could appear to have influenced the submitted work. No funder had any role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Funders | Funder number |
---|---|
Asia Diabetes Foundation | |
Bayer Pharma | |
Belgian Ministry of Public Health and Social Affairs | |
Department of Veterans | |
Faculty of Medicine, Ramathibodi Hospital, Mahidol University | 49086 |
Inova Diagnostics Inc. | |
Lady Davis Institute of Medical Research of the Jewish General Hospital | |
Liao Wun Yuk Diabetes Memorial Fund | RO1 HD39415 |
Lundbeck International | M-288 |
National Health Research Institute, Republic of China | NHRI-EX97-9706PI |
National Health Service Lothian Neuro-Oncology Endowment Fund | |
National Program for Centers of Excellence | |
National Strategic Reference Framework | |
PRONEX | |
Perpetual Trustees | FRN 83518 |
Pfizer Belgium | |
Pfizer US Pharmaceutical Inc | |
Postgraduate Research Student Support Accounts of the University of Auckland | |
Research and Development Administration Office | |
Scleroderma Society of Canada | |
Scleroderma Society of Saskatchewan | |
Sclérodermie Québec | |
Vanier Canada Graduate Scholarship | |
National Institutes of Health | T37 MD001449 |
U.S. Department of Health and Human Services | |
National Institute of Mental Health | K02 MH65919, R24 MH56858, P30 DK50456, R34 MH072925, RO1 MH073687 |
National Heart, Lung, and Blood Institute | R01 HL079235 |
National Center for Research Resources | TL1 RR024135 |
Health Resources and Services Administration | T32 GM07356, R40MC07840 |
Agency for Healthcare Research and Quality | R36 HS018246, R24 MH071604 |
U.S. Department of Education | |
Robert Wood Johnson Foundation | |
American Federation for Aging Research | |
Scleroderma Foundation | |
Pfizer | |
Ohio Board of Regents | |
National Institute on Disability and Rehabilitation Research | |
National Center for Medical Rehabilitation Research | |
Ischemia Research and Education Foundation | |
University of Michigan | H133N060032 |
University of Washington | H133N060033 |
Baylor College of Medicine | H133N060003 |
McGill University | |
Banco Santander | PQ-CNPq-2-Number 301321/2016-7, 10.1.01232.17.9 |
McGill University Health Centre | |
Canadian Institutes of Health Research | KRS-134297 |
Alberta Innovates - Health Solutions | |
Fonds de Recherche du Québec - Santé | |
National Institute for Health and Care Research | RP-PG-0606-1142 |
European Commission | |
Australian Research Council | FT130101444 |
National Health and Medical Research Council | 1002160 |
Health Research Council of New Zealand | |
European Foundation for the Study of Diabetes | |
Universität Heidelberg | RO1-MH069666, 121/2000 |
University of Melbourne | |
ZonMw | 100.003.005, 100.002.021, 945-03-047 |
Bundesministerium für Bildung und Forschung | 01GY1150, 01 GD 0101, 01 GD 9802/4 |
Ministero della Salute | |
Ministry of Health, Labour and Welfare | |
Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul | |
Tehran University of Medical Sciences and Health Services | |
Mitacs | |
Universiti Putra Malaysia | |
Universiti Sains Malaysia | |
Universidade de Macau | MYRG2015-00109-FSS |
Ministerio de Economía, Fomento y Turismo, Chile | IS130005 |
Ministry of Education, Lifelong Learning and Religious Affairs | |
Canadian Arthritis Network | |
Pro-Reitoria de Pesquisa, Universidade de São Paulo | 09.1.01689.17.7 |
Safe Work Australia | |
Innovatiefonds Zorgverzekeraars | |
Chinese Diabetes Society | |
Fundación Lilly | |
Scleroderma Society of Ontario |